Research published in GLP-1 receptor agonists are increasingly recognized as having effects that extend beyond weight loss and glucose control, said Christopher Yi, MD, board certified vascular surgeon at MemorialCare Orange Coast Medical Center in Fountain Valley, CA
Pep allows you to log both injectable GLP-1 medications and oral medications like Rybelsus
In May 2025, the FDA warned the public about unapproved or compounded semaglutide risks, noting the agency has not reviewed these products for safety, quality or effectiveness
New GLP-1 analogues, such as semaglutide and liraglutide, mimic this hormones effects by lowering blood sugar and reducing appetite
For individuals living with these overlapping conditions, addressing metabolic health may reduce some of the inflammation and hormonal imbalance that worsens endo symptoms
Cardiovascular system Cardiovascular complications (CVD) are common in patients with T2DM and a major cause of mortality (169)